Research news Archives - Page 4 of 30 - Institute for Bioengineering of Catalonia

November 17, 2022

Mini-intestinos en 3D para estudiar infecciones bacterianas

3D mini-intestine

Investigadores del Instituto de Bioingeniería de Cataluña desarrollan un modelo de intestino humano en 3D que simula las características de la mucosa intestinal y su relieve. Este mini-intestino ha permitido recrear … Read more

November 14, 2022November 14, 2022

Researchers develop a “gym on a chip” that will help to study diabetes and find new drugs to treat the disease

Coinciding with World Diabetes Day, researchers from the Institute for Bioengineering of Catalonia (IBEC) reveal a study that combines muscle and pancreatic cells on a single chip and demonstrates that … Read more

September 30, 2022

Breaking down bacteria’s protective armor to overcome antibiotic resistance

A new triple-acting antibiotic agent has managed to break through the biofilm extracellular matrix – a protective structure built by bacteria – and eliminate more than 50% of the pathogens … Read more

September 23, 2022

Identified the best routes to bring drugs inside the brain during the neurological pathology Niemann-Pick disease type A

Researchers identified how a neurological disease from the group of the lysosomal storage disorders, alters the natural entrance routes of molecules in the brain. They identified the most active ways … Read more

September 13, 2022September 13, 2022

New therapeutic target against the most common lung cancer

A study led by Jordi Alcaraz, associated researcher at IBEC and professor at the University of Barcelona, in collaboration with the Hospital Clínic, has determined that the TIMP-1 protein is … Read more

July 21, 2022July 14, 2022

A new tool against breast cancer: 3D bioprinted tumors using pig tissue

Researchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the production of artificial tumors to study the development of cancer and metastasis, and immunosuppression processes, as well as being an excellent platform for testing drugs against the disease.

March 28, 2023June 15, 2022

One step closer to self-dividing synthetic cells

For the first time, researchers have integrated cell division machinery in synthetic cells, paving the way towards truly life-like man-made systems. The study, published in the scientific journal Advanced Materials, was co-led by IBEC group leader César Rodriguez-Emmenegger.

July 15, 2022June 10, 2022

Mechanosensing: harnessing nuclear mechanics to understand health and disease

A study led by IBEC researchers, and published in Nature Cell Biology, shows that applying mechanical force to the cell nucleus affects the transport of proteins across the nuclear membrane. In doing so, this controls cellular processes and could play a key role in various diseases, such as cancer. This entails a novel approach to understanding aspects of cancer invasion and metastasis, opening the door to potential new techniques for diagnosis and therapy.

September 15, 2022May 20, 2022

The first light-controlled drug that could improve the hearing of people with cochlear implants

Researchers at the Institute for Bioengineering of Catalonia (IBEC) in Spain and the University Medical Center Göttingen in Germany achieve, for the first time, in vivo light-activated auditory stimulation without the need for genetic manipulation. This new light-controlled drug, capable of triggering the neural pathways involved in hearing, can contribute to improving the spectral resolution of cochlear implants used by people with profound hearing loss or deafness.

May 25, 2022May 18, 2022

Nanorobots to fight bacterial infections

Researchers develop self-contained micro- and nanorobots with antimicrobial activity, capable of attacking bacteria in the site of infection. The work has been led by Samuel Sánchez (Institute for Bioengineering of Catalunya (IBEC) and Cesar de la Fuente-Núñez (University of Pennsylvania, USA). The new technology, tested in mice, is a valuable tool for the treatment of bacterial infections in a controlled and localized way. In a future not so far, it could help combat infections.